2021
High Impact Journal Papers Led by CUHK
-
Nasopharyngeal carcinoma: an evolving paradigm
Nature Reviews Clinical Oncology
-
Cognitive Impairment in Survivors of Pediatric Acute Lymphoblastic Leukemia Treated With Chemotherapy Only
2021
Journal of Clinical Oncology
-
Long-term Effects of Repeat Hepatectomy vs Percutaneous Radiofrequency Ablation Among Patients With Recurrent Hepatocellular Carcinoma: A Randomized Clinical Trial
2020
JAMA Oncology
-
Plasma DNA End-Motif Profiling as a Fragmentomic Marker in Cancer, Pregnancy, and Transplantation
2020
Cancer Discovery
-
Updated overall survival and final progression-free survival data for patients with treatment-naive advanced ALK-positive non-small-cell lung cancer in the ALEX study
2020
Annals of Oncology
-
Integrating postradiotherapy plasma Epstein-Barr virus DNA and TNM stage for risk stratification of nasopharyngeal carcinoma to adjuvant therapy
2020
Annals of Oncology
-
Genomic origin and EGFR-TKI treatments of pulmonary adenosquamous carcinoma
2020
Annals of Oncology
-
Neoadjuvant Three-Dimensional Conformal Radiotherapy for Resectable Hepatocellular Carcinoma With Portal Vein Tumor Thrombus: A Randomized, Open-Label, Multicenter Controlled Study
2019
Journal of Clinical Oncology
-
Complementary roles of MRI and endoscopic examination in the early detection of nasopharyngeal carcinoma
2019
Annals of Oncology
-
Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial
2019
The Lancet